KronosMD, Inc. has initiated a crowdfunding effort to raise up to $5 million through the sale of preferred stock. This offering, filed on October 27, 2026, is a strategic move aimed at securing necessary funding to support the company's growth and operations.

The preferred stock offering includes 10,000 shares priced at $1.00 each, with the potential for over-subscription. The intermediary involved in this crowdfunding initiative will receive 4.9% of the final raised funds, along with a $3,500 listing fee. This approach reflects a growing trend among small-cap companies looking for alternative financing methods.

Background on KronosMD

KronosMD, Inc. is a corporation incorporated in Colorado on October 7, 2022. The company operates out of Thousand Oaks, California, with a business address at 1000 Newbury Rd., Suite 290 B, Thousand Oaks, CA 91320. As of the most recent fiscal year, the company reported total assets of approximately $5.17 million, though it has yet to generate revenue, with a net income loss of $10,179.

The filing indicates that KronosMD has one current employee, highlighting its status as a small entity in the competitive landscape of crowdfunding and small-cap investments.

What the Filing Says

The filing states, "The maximum offering amount is $5,000,000.00, and the deadline for this offering is April 18, 2027." This timeline suggests that KronosMD is looking to capitalize on the current market environment to secure funds for its future endeavors.

Impact on the Industry

This crowdfunding initiative could have significant implications for the industry, particularly for other small-cap companies seeking similar funding avenues. As more companies explore crowdfunding, the competitive landscape may shift, prompting traditional financing methods to adapt.

What's Next

The filing does not specify what happens next regarding the offering, but it sets the stage for potential investor engagement and further developments in KronosMD's growth strategy.